Cargando…
The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40
BACKGROUND: Tumor debulking surgery followed by adjuvant chemotherapy or radiotherapy is a standard treatment for many solid malignancies. Although this approach can be effective, it often has limited success against recurrent or metastatic cancers and new multimodality approaches are needed. Adjuva...
Autores principales: | Khong, Andrea, Cleaver, Amanda L, Fahmi Alatas, Muhammad, Wylie, Ben C, Connor, Theresa, Fisher, Scott A, Broomfield, Steve, Lesterhuis, Willem J, Currie, Andrew J, Lake, Richard A, Robinson, Bruce W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320570/ https://www.ncbi.nlm.nih.gov/pubmed/25518732 http://dx.doi.org/10.1186/1471-2407-14-969 |
Ejemplares similares
-
Neoadjuvant anti-tumor vaccination prior to surgery enhances survival
por: Fisher, Scott A, et al.
Publicado: (2014) -
Treatment of Verrucous Carcinoma of the Lower Lip with Topical Imiquimod (Aldara®) and Debulking Therapy
por: Kwon, Hyok Bu, et al.
Publicado: (2011) -
Effective Melanoma Immunotherapy in Mice by the Skin-Depigmenting Agent Monobenzone and the Adjuvants Imiquimod and CpG
por: van den Boorn, Jasper G., et al.
Publicado: (2010) -
Restoration of defective cross-presentation in tumors by gemcitabine
por: McDonnell, Alison M, et al.
Publicado: (2015) -
Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations
por: Lesterhuis, W. Joost, et al.
Publicado: (2015)